DK1691824T3 - Proteiner tilhörende BCL-2-familien og fragmenter deraf og deres anvendelse i cancerpatienter - Google Patents
Proteiner tilhörende BCL-2-familien og fragmenter deraf og deres anvendelse i cancerpatienterInfo
- Publication number
- DK1691824T3 DK1691824T3 DK04797460T DK04797460T DK1691824T3 DK 1691824 T3 DK1691824 T3 DK 1691824T3 DK 04797460 T DK04797460 T DK 04797460T DK 04797460 T DK04797460 T DK 04797460T DK 1691824 T3 DK1691824 T3 DK 1691824T3
- Authority
- DK
- Denmark
- Prior art keywords
- fragments
- bcl
- family
- cancer patients
- proteins belonging
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 102000051485 Bcl-2 family Human genes 0.000 title abstract 2
- 108700038897 Bcl-2 family Proteins 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title abstract 2
- 102000007079 Peptide Fragments Human genes 0.000 abstract 2
- 108010033276 Peptide Fragments Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52311903P | 2003-11-19 | 2003-11-19 | |
| DKPA200301716 | 2003-11-19 | ||
| PCT/DK2004/000799 WO2005049073A2 (en) | 2003-11-19 | 2004-11-18 | Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1691824T3 true DK1691824T3 (da) | 2009-07-06 |
Family
ID=39149116
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04797460T DK1691824T3 (da) | 2003-11-19 | 2004-11-18 | Proteiner tilhörende BCL-2-familien og fragmenter deraf og deres anvendelse i cancerpatienter |
| DK09154734.9T DK2087904T3 (da) | 2003-11-19 | 2004-11-18 | Terapeutisk anvendelse af peptider stammende fra Bcl-XL-protein i cancerpatienter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09154734.9T DK2087904T3 (da) | 2003-11-19 | 2004-11-18 | Terapeutisk anvendelse af peptider stammende fra Bcl-XL-protein i cancerpatienter |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7842294B2 (da) |
| EP (2) | EP1691824B1 (da) |
| JP (2) | JP4926714B2 (da) |
| KR (2) | KR101284237B1 (da) |
| CN (1) | CN1921878B (da) |
| AT (1) | ATE424842T1 (da) |
| AU (1) | AU2004290866B2 (da) |
| CA (1) | CA2546794C (da) |
| DE (1) | DE602004019965D1 (da) |
| DK (2) | DK1691824T3 (da) |
| ES (2) | ES2436429T3 (da) |
| HK (1) | HK1101131A1 (da) |
| MX (1) | MXPA06005738A (da) |
| PL (2) | PL1691824T3 (da) |
| PT (1) | PT1691824E (da) |
| RU (1) | RU2367468C2 (da) |
| WO (1) | WO2005049073A2 (da) |
| ZA (1) | ZA200604866B (da) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8283325B2 (en) * | 2004-10-19 | 2012-10-09 | Massachusetts Institute Of Technology | Virus scaffold for self-assembled, flexible and light lithium battery |
| US7892559B2 (en) | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| ES2661082T3 (es) * | 2003-01-30 | 2018-03-27 | Survac Aps | Péptidos derivados de survivina y uso de los mismos |
| US7612162B2 (en) | 2004-09-21 | 2009-11-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response |
| AU2011203535B2 (en) * | 2005-02-04 | 2012-10-11 | Survac Aps | Survivin peptide vaccine |
| DK1853305T3 (da) * | 2005-02-04 | 2014-12-01 | Survac Aps | Survivin-peptidvaccine |
| AU2006347606B2 (en) * | 2005-09-09 | 2012-10-11 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for inhibiting cell death or enhancing cell proliferation |
| EP2361930A3 (en) | 2007-03-26 | 2011-10-26 | Dako Denmark A/S | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| EP3023436A1 (en) * | 2007-07-03 | 2016-05-25 | Dako Denmark A/S | Improved methods for generation, labeling and use of mhc multimers |
| WO2009039854A2 (en) * | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US10968269B1 (en) | 2008-02-28 | 2021-04-06 | Agilent Technologies, Inc. | MHC multimers in borrelia diagnostics and disease |
| EP2254592B1 (en) * | 2008-02-28 | 2019-06-05 | Dako Denmark A/S | Mhc multimers in borrelia diagnostics and disease |
| IL287311B1 (en) | 2008-05-16 | 2024-02-01 | Taiga Biotechnologies Inc | Antibodies and processes for their preparation |
| EP2313516A4 (en) * | 2008-07-16 | 2012-04-04 | Burnham Inst Medical Research | COMPOSITIONS AND METHODS FOR MODULATING THE NOD LIKE RECEPTOR ACTIVITY AND THEIR USE |
| US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
| EP2966084B1 (en) | 2008-08-28 | 2018-04-25 | Taiga Biotechnologies, Inc. | Modulators of myc, methods of using the same and methods of identifying agents that modulate myc |
| GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
| WO2010037397A1 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cmv immune monitoring |
| US20110318380A1 (en) * | 2008-10-01 | 2011-12-29 | Dako Denmark A/S | MHC Multimers in Cancer Vaccines and Immune Monitoring |
| US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| CA2740779A1 (en) * | 2008-10-17 | 2010-04-22 | University Of Miami | Tumor vaccine |
| EP2491116A4 (en) * | 2009-10-22 | 2013-12-11 | Univ Jefferson | CELL-BASED ANTI-RISK COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE |
| CA2792910A1 (en) | 2010-03-11 | 2011-09-15 | Yusuke Nakamura | Hjurp peptides and vaccines including the same |
| ES2930809T3 (es) | 2010-08-24 | 2022-12-22 | Univ Pittsburgh Commonwealth Sys Higher Education | Vacunas contra el cáncer cerebral basadas en el péptido receptor de interleucina-13 alfa 2 |
| DK3536334T3 (da) | 2012-05-16 | 2021-09-13 | Stemline Therapeutics Inc | Cancer stamcelle målrettede cancer vacciner |
| CN114645015A (zh) * | 2012-07-20 | 2022-06-21 | 泰加生物工艺学公司 | 造血区室的增强的重建和自动重建 |
| CN105228640B (zh) * | 2013-02-26 | 2018-01-16 | 王荣福 | Phf20和jmjd3组合物及其在肿瘤免疫治疗中的使用方法 |
| CN105163744A (zh) * | 2013-03-01 | 2015-12-16 | 美国卫生和人力服务部 | 从肿瘤中产生肿瘤反应性t细胞的富集群的方法 |
| US9704181B2 (en) * | 2014-05-06 | 2017-07-11 | International Business Machines Corporation | Real-time social group based bidding system |
| US10583156B2 (en) | 2016-12-02 | 2020-03-10 | Taiga Biotechnologies, Inc. | Nanoparticle formulations |
| WO2018138257A1 (en) * | 2017-01-27 | 2018-08-02 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| AR110857A1 (es) | 2017-01-27 | 2019-05-08 | Immatics Biotechnologies Gmbh | Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer |
| CR20210129A (es) * | 2017-01-27 | 2021-03-26 | Immatics Biotechnologies Gmbh | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer (divisional exp. 2019-388) |
| MX2021002449A (es) | 2018-09-04 | 2021-08-05 | Treos Bio Ltd | Vacunas peptidicas. |
| CN113355432A (zh) * | 2021-05-12 | 2021-09-07 | 甘肃农业大学 | Bmf作为细胞凋亡标志物的应用 |
| WO2022245249A1 (ru) * | 2021-05-17 | 2022-11-24 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | Пептидные соединения для индукции апоптоза в опухолевой клетке |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| JP3608788B2 (ja) | 1992-08-31 | 2005-01-12 | ルドヴィグ・インスティテュート・フォー・キャンサー・リサーチ | Ｍａｇｅ−３遺伝子から誘導されてｈｌａ−ａ１により提示される単離されたノナペプチドおよびそれらの用途 |
| US5470955A (en) | 1993-02-02 | 1995-11-28 | Dartmouth College | Antibodies which specifically bind mcl-1 polypeptide |
| US5646008A (en) * | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
| US5700638A (en) * | 1993-08-26 | 1997-12-23 | Washington University | Cell death regulator |
| GB9320597D0 (en) | 1993-10-06 | 1993-11-24 | Proteus Molecular Design | Improvements in and realting to vaccines |
| US6096313A (en) | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US5789201A (en) * | 1996-02-23 | 1998-08-04 | Cocensys, Inc. | Genes coding for bcl-y a bcl-2 homologue |
| KR100645448B1 (ko) | 1996-11-20 | 2006-11-13 | 예일 유니버시티 | 세포 아폽토시스를 저해하는 설바이빈 단백질 및 이를 조절하는 방법 |
| WO1998058541A1 (en) | 1997-06-24 | 1998-12-30 | Dana-Farber Cancer Institute, Inc. | Modulation of apoptosis |
| AU3471200A (en) | 1999-11-16 | 2001-05-30 | Dartmouth College | Mcl-1 gene regulatory elements and a pro-apoptotic mcl-1 variant |
| CA2390662A1 (en) * | 1999-12-14 | 2001-06-21 | The Burnham Institute | Bcl-g polypeptides, encoding nucleic acids and methods of use |
| AU2001271426A1 (en) | 2000-07-17 | 2002-01-30 | Washington University | Modulation of apoptosis |
| WO2002072627A2 (en) | 2001-03-09 | 2002-09-19 | Callistogen Ag | Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| US7892559B2 (en) * | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| AU2004228106B2 (en) | 2003-04-11 | 2010-05-13 | Survac Aps | Therapeutic cancer vaccine |
-
2004
- 2004-11-18 AT AT04797460T patent/ATE424842T1/de active
- 2004-11-18 ES ES09154734.9T patent/ES2436429T3/es active Active
- 2004-11-18 CN CN2004800407050A patent/CN1921878B/zh active Active
- 2004-11-18 US US10/580,016 patent/US7842294B2/en active Active
- 2004-11-18 PL PL04797460T patent/PL1691824T3/pl unknown
- 2004-11-18 DK DK04797460T patent/DK1691824T3/da active
- 2004-11-18 AU AU2004290866A patent/AU2004290866B2/en active Active
- 2004-11-18 CA CA2546794A patent/CA2546794C/en active Active
- 2004-11-18 ZA ZA200604866A patent/ZA200604866B/en unknown
- 2004-11-18 ES ES04797460T patent/ES2323588T3/es active Active
- 2004-11-18 DE DE602004019965T patent/DE602004019965D1/de active Active
- 2004-11-18 JP JP2006540170A patent/JP4926714B2/ja active Active
- 2004-11-18 RU RU2006121466/15A patent/RU2367468C2/ru active
- 2004-11-18 MX MXPA06005738A patent/MXPA06005738A/es active IP Right Grant
- 2004-11-18 WO PCT/DK2004/000799 patent/WO2005049073A2/en active Application Filing
- 2004-11-18 DK DK09154734.9T patent/DK2087904T3/da active
- 2004-11-18 PL PL09154734T patent/PL2087904T3/pl unknown
- 2004-11-18 EP EP04797460A patent/EP1691824B1/en active Active
- 2004-11-18 KR KR1020127016885A patent/KR101284237B1/ko active IP Right Grant
- 2004-11-18 PT PT04797460T patent/PT1691824E/pt unknown
- 2004-11-18 KR KR1020067012186A patent/KR101216655B1/ko active IP Right Grant
- 2004-11-18 EP EP09154734.9A patent/EP2087904B1/en active Active
-
2007
- 2007-08-23 HK HK07109167.1A patent/HK1101131A1/xx unknown
-
2011
- 2011-09-12 JP JP2011198605A patent/JP5502823B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1691824T3 (da) | Proteiner tilhörende BCL-2-familien og fragmenter deraf og deres anvendelse i cancerpatienter | |
| CY1119127T1 (el) | Επιτοποι σκληροστινης | |
| CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
| ATE482972T1 (de) | Tgf-beta1-bindende und geträgerte peptide | |
| CA2523467C (en) | Treatment of t-cell mediated diseases | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| SE0103754L (sv) | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid | |
| AU2003270643A1 (en) | Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence | |
| HK1112367A1 (en) | Survivin peptide vaccine | |
| CY1118930T1 (el) | Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων | |
| ATE460176T1 (de) | Mikrosomvakzin | |
| EA200801411A1 (ru) | Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| ATE412671T1 (de) | Modifizierter faktor viii | |
| NO20043210L (no) | Tolerogene peptider fra myelin-basisprotein | |
| CY1114002T1 (el) | Κοντα βιοδραστικα πεπτιδια για κυτταρικη και ανοσολογικη τροποποιηση | |
| ATE473756T1 (de) | Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs | |
| DK1290160T3 (da) | Humane Pellino-polypeptider | |
| NO20060675L (no) | Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider | |
| ATE484290T1 (de) | Peptid mit antitumoraler wirkung | |
| HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
| ATE400581T1 (de) | Peptid-antioxidantien aus sojaproteinen | |
| DK1939217T3 (da) | Plasmider kodende for p185neu-proteinsekvensvarianter og terapeutiske anvendelser deraf | |
| CY1108761T1 (el) | Απενεργοποιημενες κυτοκινες για ανοσοποιηση | |
| ATE505538T1 (de) | Dna-vektoren |